FDA approval of Exablate Neuro for the treatment of tremor-dominant Parkinson’s disease
InSightec has announced that The Center for Devices and Radiological Health (CDRH) of the US Food and Drug Administration (FDA) has approved an expansion...
Percutaneous PNS may hold the potential to shift the chronic pain management paradigm
A recent study demonstrates the potential value of percutaneous peripheral nerve stimulation (PNS) for chronic low back pain. Data reported by Christopher A. Gilmore...
Nuvectra receives full-body MR-conditional CE Mark approval for Algovita
Nuvectra has announced that it has received full-body MR-conditional approval for the Company’s Algovita spinal cord stimulation (SCS) system from its European Notified Body,...
Nuvectra receives FDA head-only MR-conditional approval for Algovita
Nuvectra has announced that it has received US Food and Drug Administration (FDA) head-only MR-conditional approval for the company’s Algovita spinal cord stimulation (SCS) system.
Scott...
(Visited 3,143 times, 5 visits today)
